Cashu
Insulet Corp. Initiates Voluntary Recall of Omnipod 5 Pods Due to Safety Concerns
20 days ago
Stocks
Health Care
podd
Insulet
NASDAQ: PODD
-2.73 (-1.32%)
204.31
USD
At close at Apr 03, 20:36 UTC
Overview
Loading chart...
Key Stats
Market Cap
14.37B
Dividend Yield
0.00%
P/E Ratio
58.17
EPS
5.98
Revenue
2.07B
Avg. Volume
900.22K
About
What does PODD do?
Insulet, headquartered in Acton, Massachusetts, develops and markets insulin infusion systems, including the Omnipod 5 Automated Insulin Delivery System, for insulin-dependent diabetes. The company employs 3,000 staff and went public in 2007.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.